 |
|
|
| |
Metabolic, Bone, Renal, Inflammatory and Lipodystrophic Marker Analysis in INROADS, a Multicenter, Single-Arm, Open-Label Study of a Once-Daily Nucleoside/tide-Sparing Regimen of Etravirine (ETR) and Darunavir/Ritonavir (DRV/r) as Dual Therapy in Early Treatment-Experienced Subjects
|
| |
| |
Reported by Jules Levin
IDSA 2013 Oct 2-6 San Francisco, CA
Moti Ramgopal,1 Fritz Bredeek,2 Joseph Gathe,3 Robert Ryan,4 Bruce Coate,4 David Anderson5
1Midway Immunology and Research Center, Ft. Pierce, Florida, USA; 2Metropolis Medical, San Francisco, California, USA; 3Therapeutic Concepts, Houston, Texas, USA; 4Janssen Research & Development, Titusville, New Jersey, USA; 5Janssen Services, LLC, Titusville, New Jersey, USA
|
| |
|
|
|
|
|
